The Use of FDG-PET in conjunction with PSMA-PET in Prostate Cancer

被引：0
|
作者：
Gokhale, Saket [1 ]
Kuang, Angie [1 ]
Teichner, Eric [1 ]
Subtirelu, Robert [1 ]
Werner, Thomas [2 ]
Hoilund-Carlsen, Poul Flemming [3 ]
Revheim, Mona-Elisabeth [4 ,5 ]
Alavi, Abass [1 ]
Raynor, William [6 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Penn, Hosp, Philadelphia, PA USA
[3] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[4] Oslo Univ Hosp, Oslo, Norway
[5] Univ Oslo, Oslo, Norway
[6] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1083
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Detection of unexpected prostate cancer with FDG-PET/CT
    Ishimori, Takayoshi
    Ishibashi, Mana
    Yamada, Tsuyoshi
    Watanabe, Yuji
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [32] Utility of FDG-PET in clinical neuroendocrine prostate cancer
    Spratt, Daniel E.
    Gavane, Somali
    Tarlinton, Lisa
    Fareedy, Shoaib B.
    Doran, Michael G.
    Zelefsky, Michael J.
    Osborne, Joseph R.
    PROSTATE, 2014, 74 (11): : 1153 - 1159
  • [33] Comparison between pelvic PSMA-PET/MR and whole-body PSMA-PET/CT for the initial evaluation of prostate cancer: a proof of concept study
    Liran Domachevsky
    Hanna Bernstine
    Natalia Goldberg
    Meital Nidam
    Onofrio A. Catalano
    David Groshar
    European Radiology, 2020, 30 : 328 - 336
  • [34] Das Primärstaging mittels PSMA-PET verbessert die Vorhersage von ProstatakarzinomrezidivenPrimary staging with PSMA-PET improves the prediction of prostate cancer recurrence
    Leubet Yirga
    Boris Hadaschik
    Lukas Püllen
    Die Urologie, 2023, 62 (12) : 1326 - 1327
  • [35] Comparison between pelvic PSMA-PET/MR and whole-body PSMA-PET/CT for the initial evaluation of prostate cancer: a proof of concept study
    Domachevsky, Liran
    Bernstine, Hanna
    Goldberg, Natalia
    Nidam, Meital
    Catalano, Onofrio A.
    Groshar, David
    EUROPEAN RADIOLOGY, 2020, 30 (01) : 328 - 336
  • [36] PSMA-PET is superior to choline-PET based SABR for ADT deferral in oligometastatic prostate cancer
    Deijen, C.
    Vrijenhoek, G.
    Vogel, W.
    Moonen, L.
    Pos, F.
    Van der Poel, H.
    Borst, G.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S622 - S622
  • [37] PSMA-PET guided stereotactic body radiotherapy for bone oligorecurrent prostate cancer
    Cuccia, F.
    Mazzola, R.
    Pastorello, E.
    Ingrosso, G.
    Franzese, C.
    Scorsetti, M.
    Figlia, V.
    Giaj-Levra, N.
    Nicosia, L.
    Rigo, M.
    Ricchetti, F.
    Vitale, C.
    Attina, G.
    Ruggieri, R.
    Alongi, F.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S61 - S62
  • [38] FDG-PET and PET/CT in Colorectal Cancer
    Lonneux, Max
    PET CLINICS, 2008, 3 (02) : 147 - +
  • [39] PSMA-PET/CT Detection of Prostate Cancer Metastasis to Thyroid and Cricoid Cartilages
    Sesler, Aaron
    Raichandani, Surbhi
    Eichhorn, Joshua
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [40] PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer
    E. Lopci
    G. Lughezzani
    A. Castello
    P. Colombo
    P. Casale
    A. Saita
    N. M. Buffi
    G. Guazzoni
    A. Chiti
    M. Lazzeri
    Clinical and Translational Oncology, 2021, 23 : 172 - 178
12345